Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $4.41 Million - $5.47 Million
-19,601 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $1.27 Million - $1.56 Million
-5,732 Reduced 22.63%
19,601 $4.53 Million
Q2 2021

Aug 09, 2021

SELL
$180.55 - $233.54 $492,359 - $636,863
-2,727 Reduced 9.72%
25,333 $5.82 Million
Q1 2021

May 07, 2021

SELL
$164.32 - $212.72 $869,417 - $1.13 Million
-5,291 Reduced 15.86%
28,060 $5.24 Million
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $546,757 - $723,492
-4,191 Reduced 11.16%
33,351 $5.63 Million
Q3 2020

Nov 09, 2020

SELL
$146.22 - $169.13 $74,279 - $85,918
-508 Reduced 1.34%
37,542 $5.56 Million
Q2 2020

Aug 11, 2020

SELL
$136.42 - $164.18 $10,640 - $12,806
-78 Reduced 0.2%
38,050 $6.25 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $529,177 - $654,970
-4,445 Reduced 10.44%
38,128 $5.29 Million
Q4 2019

Feb 05, 2020

SELL
$106.92 - $132.43 $17 Million - $21.1 Million
-159,076 Reduced 78.89%
42,573 $5.6 Million
Q3 2019

Nov 04, 2019

SELL
$106.79 - $116.16 $3.27 Million - $3.56 Million
-30,619 Reduced 13.18%
201,649 $22.6 Million
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $2.66 Million - $3.11 Million
-24,013 Reduced 9.37%
232,268 $25.7 Million
Q1 2019

May 02, 2019

BUY
$111.31 - $131.02 $18.9 Million - $22.3 Million
170,036 Added 197.15%
256,281 $33.3 Million
Q4 2018

Feb 04, 2019

BUY
$105.9 - $118.64 $9.13 Million - $10.2 Million
86,245 New
86,245 $9.98 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Newport Trust CO Portfolio

Follow Newport Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newport Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Newport Trust CO with notifications on news.